Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
IntelyCare Announces Partnership with DailyPay to Provide Nursing Professionals Faster Access to Earned Pay
IntelyCare, the leading intelligent workforce management solution for post-acute facilities, has teamed up with DailyPay […]
Therapeutic Solutions International Identifies and Files Patent on Novel Mechanism of Action of Its FDA Phase III Cleared JadiCell™ Treatment of COVID-19 and Delta Variant
Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today novel data and filing of a […]
AI in Drug Discovery Requires Extensive Chemical Libraries, Finds IDTechEx
AI in drug discovery is a field that has received an immense increase in interest, […]
Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline and Expand Single Cell Analysis Drug Development Platform
Immunitas Therapeutics (“Immunitas”), a single cell genomics-based therapeutics company, today announced the completion of a $58 […]
Holmusk Signs Agreements with UTHealth and The Harris Center
Holmusk, a leading global data science and health technology company building the world’s largest Real-World […]
Gracell Biotechnologies Signs Exclusive License Agreement with FutureGen Biopharm to Develop Engineered Immune Cell Therapies Targeting Claudin 18.2 in Solid Tumors
Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to developing highly […]
Allina Health Selects Icertis To Accelerate Digital Transformation of Contracting
Icertis, the contract intelligence company that pushes the boundaries of what’s possible with contract lifecycle […]
Ultromics Raises $33M in Series B Funding to Help Transform Cardiac Disease Treatment
Ultromics, a leader in AI enabled cardiovascular imaging solutions, announced today that it has raised […]
Lilly Announces Leadership Changes and Formation of Neuroscience and Immunology Business Units
Eli Lilly and Company (NYSE: LLY) today announced executive leadership changes and the creation of neuroscience […]
3D Bioprinting Market Size to Reach USD 2,687.8 Million in 2027
The global 3D bioprinting market size is expected to reach USD 2,687.8 Million in 2027 at a CAGR of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more